ENTRY       D11420                      Drug
NAME        Prasinezumab (USAN/INN)
FORMULA     C6452H9994N1718O2014S44
EXACT_MASS  145174.0137
MOL_WEIGHT  145263.551
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS NYGMSWVRQA PGKGLEWVAS ISSGGGSTYY
            PDNVKGRFTI SRDDAKNSLY LQMNSLRAED TAVYYCARGG AGIDYWGQGT LVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA PELLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKSIQTLL YSSNQKNYLA WFQQKPGKAP KLLIYWASIR
            KSGVPSRFSG SGSGTDFTLT ISSLQPEDLA TYYCQQYYSY PLTFGGGTKL EIKRTVAAPS
            VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
            LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (Disulfide bridge: H22-H96, H143-H199, H219-L220, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'220, H'260-H'320, H'366-H'424, L23-L94, L140-L'200, L'23-L'94, L'140-L'200)
  TYPE      Peptide
EFFICACY    Antiparkinsonian, Anti-synuclein alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of Parkinson's disease
TARGET      SNCA [HSA:6622] [KO:K04528]
  PATHWAY   hsa05012(6622)  Parkinson disease
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Membrane trafficking
                SNCA
                 D11420  Prasinezumab (USAN/INN)
DBLINKS     CAS: 1960462-19-4
            PubChem: 384585397
///
